Safety and Effectiveness of Vedolizumab in Patients with Moderate-to-Severe Ulcerative Colitis: An Interim Analysis of a Japanese Post-Marketing Surveillance Study

INTRODUCTION: This ongoing post-marketing surveillance monitors the long-term safety and effectiveness of vedolizumab in routine clinical practice in patients with moderate-to-severe ulcerative colitis (UC) in Japan. This interim analysis assessed induction-phase data, covering the initial three dos...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuoka, Katsuyoshi, Hisamatsu, Tadakazu, Mikami, Yohei, Yamamoto, Takayuki, Motoya, Satoshi, Shinzaki, Shinichiro, Iwakiri, Ryuichi, Sugiura, Kenkichi, Nishimura, Kunihiko, Kajita, Mika, Fernandez, Jovelle L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220148/
https://www.ncbi.nlm.nih.gov/pubmed/37140705
http://dx.doi.org/10.1007/s12325-023-02500-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220148/
https://www.ncbi.nlm.nih.gov/pubmed/37140705
http://dx.doi.org/10.1007/s12325-023-02500-6

Ejemplares similares